Similar articles for PMID: 30148440

Year	Number of Results
1991	1
1993	1
2001	1
2006	3
2007	3
2008	2
2009	5
2010	3
2011	6
2012	3
2013	5
2014	4
2015	9
2016	20
2017	28
2018	25
2019	24
2020	24
2021	28
2022	20
2023	8
2024	0

1

Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology.

Carrara G, Bortoluzzi A, Sakellariou G, Silvagni E, Zanetti A, Govoni M, Scirè CA. Carrara G, et al. Clin Exp Rheumatol. 2019 Jan-Feb;37(1):60-66. Epub 2018 Jul 18. Clin Exp Rheumatol. 2019. PMID: 30148440 Free article.

2

Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.

Silvagni E, Bortoluzzi A, Carrara G, Zanetti A, Govoni M, Scirè CA. Silvagni E, et al. BMJ Open. 2018 Sep 11;8(9):e021447. doi: 10.1136/bmjopen-2017-021447. BMJ Open. 2018. PMID: 30206082 Free PMC article.

3

Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases.

D'Amico ME, Silvagni E, Carrara G, Zanetti A, Govoni M, Scirè CA, Bortoluzzi A. D'Amico ME, et al. Scand J Rheumatol. 2021 Sep;50(5):333-342. doi: 10.1080/03009742.2020.1855365. Epub 2021 Mar 4. Scand J Rheumatol. 2021. PMID: 33660559

4

Can the adherence to quality of care indicators for early rheumatoid arthritis in clinical practice reduce risk of hospitalisation? Retrospective cohort study based on the Record Linkage of Rheumatic Disease study of the Italian Society for Rheumatology.

Zanetti A, Scirè CA, Argnani L, Carrara G, Zambon A; Italian Society for Rheumatology. Zanetti A, et al. BMJ Open. 2020 Sep 29;10(9):e038295. doi: 10.1136/bmjopen-2020-038295. BMJ Open. 2020. PMID: 32994247 Free PMC article.

5

Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort.

Shimizu Y, Tanaka E, Inoue E, Shidara K, Sugimoto N, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H. Shimizu Y, et al. Mod Rheumatol. 2018 May;28(3):461-467. doi: 10.1080/14397595.2017.1369926. Epub 2017 Sep 14. Mod Rheumatol. 2018. PMID: 28880684

6

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.

Ramiro S, Gaujoux-Viala C, Nam JL, Smolen JS, Buch M, Gossec L, van der Heijde D, Winthrop K, Landewé R. Ramiro S, et al. Ann Rheum Dis. 2014 Mar;73(3):529-35. doi: 10.1136/annrheumdis-2013-204575. Epub 2014 Jan 8. Ann Rheum Dis. 2014. PMID: 24401994 Review.

7

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.

Frisell T, Baecklund E, Bengtsson K, Di Giuseppe D, Forsblad-d'Elia H, Askling J; ARTIS Study group. Frisell T, et al. Ann Rheum Dis. 2018 May;77(5):650-657. doi: 10.1136/annrheumdis-2017-212395. Epub 2017 Dec 13. Ann Rheum Dis. 2018. PMID: 29237621 Free PMC article.

8

Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Rutherford AI, Subesinghe S, Hyrich KL, Galloway JB. Rutherford AI, et al. Ann Rheum Dis. 2018 Jun;77(6):905-910. doi: 10.1136/annrheumdis-2017-212825. Epub 2018 Mar 28. Ann Rheum Dis. 2018. PMID: 29592917

9

Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.

Bengtsson K, Jacobsson LT, Rydberg B, Kvist G, Torstenson T, Dehlin M, Hilme E, Lindhé A, Wallerstedt SM, Forsblad-d'Elia H. Bengtsson K, et al. BMC Musculoskelet Disord. 2016 Dec 12;17(1):499. doi: 10.1186/s12891-016-1354-7. BMC Musculoskelet Disord. 2016. PMID: 27955647 Free PMC article.

10

A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.

Jones G, Hall S, Bird P, Littlejohn G, Tymms K, Youssef P, Chung E, Barrett R, Button P. Jones G, et al. Int J Rheum Dis. 2018 Aug;21(8):1581-1590. doi: 10.1111/1756-185X.13243. Epub 2017 Dec 5. Int J Rheum Dis. 2018. PMID: 29205926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

188 results

Results by year